Option Care Health Inc (OPCH)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $4.74B
Last updated: Nov 17, 2026 at 11:06 AM ET
Option Care Health Inc (OPCH) Financials: Revenue, Profit and Cash Flow
Option Care Health reported revenue of $5.65B for the fiscal year ended Dec 31, 2025, up 13.0% from the year before. That year, net income was $207.59M with a net margin of 3.7%, operating cash flow was $258.45M and free cash flow was $217.14M. The quarter ended Sep 30, 2026 had revenue of $1.49B and net income of $57.43M.
Revenue and Margins
The operating margin was 6.0% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $935.59M, a compound annual rate of 22.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $5.65B | +13.0% | 19.3% | 6.0% | 3.7% |
| Dec 2024 | $5.00B | +16.2% | 20.3% | 6.4% | 4.2% |
| Dec 2023 | $4.30B | +9.1% | 22.8% | 7.3% | 6.2% |
| Dec 2022 | $3.94B | +14.7% | 22.0% | 6.1% | 3.8% |
| Dec 2021 | $3.44B | +13.4% | 22.7% | 5.5% | 4.1% |
| Dec 2020 | $3.03B | +31.3% | 22.5% | 3.7% | -0.3% |
| Dec 2019 | $2.31B | +19.1% | 22.2% | 0.0% | -3.3% |
| Dec 2018 | $1.94B | +6.1% | 21.8% | 2.0% | -0.3% |
| Dec 2017 | $1.83B | +95.4% | 24.4% | 1.5% | 0.2% |
| Dec 2016 | $935.59M | N/A | 28.0% | -1.2% | -4.6% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 2.0% from the year before. In the quarter ended Sep 2026, net income rose 10.8% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.65B | $5.00B | $4.30B | $3.94B | $3.44B | $3.03B | $2.31B | $1.94B | $1.83B | $935.59M |
| Cost of revenue | $4.56B | $3.99B | $3.32B | $3.08B | $2.66B | $2.35B | $1.80B | $1.52B | $1.38B | $700.12M |
| Gross profit | $1.09B | $1.01B | $981.22M | $866.92M | $779.61M | $682.26M | $513.00M | $422.21M | $446.00M | $262.08M |
| Operating income | $337.91M | $321.83M | $314.60M | $240.23M | $190.84M | $110.75M | -$319.00K | $38.27M | $27.28M | -$10.99M |
| Net income | $207.59M | $211.82M | $267.09M | $150.56M | $139.90M | -$8.08M | -$75.92M | -$6.12M | $3.88M | -$42.77M |
| EBITDA | $404.89M | $394.79M | $471.11M | $324.19M | $251.27M | $182.63M | $55.10M | $80.20M | N/A | $29.48M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.44B | $1.35B | $1.47B | $1.44B | $1.42B | $1.33B | $1.35B | $1.28B | $1.23B | $1.15B | $1.12B |
| Gross profit | $284.97M | $267.25M | $262.01M | $282.90M | $272.90M | $269.04M | $263.05M | $268.38M | $256.75M | $249.37M | $238.50M | $247.12M |
| Operating income | $89.22M | $85.14M | $72.55M | $91.50M | $84.51M | $82.71M | $79.19M | $87.04M | $85.09M | $80.67M | $69.03M | $84.56M |
| Net income | $57.43M | $53.91M | $45.34M | $58.50M | $51.82M | $50.52M | $46.74M | $60.13M | $53.86M | $53.04M | $44.79M | $57.18M |
Balance Sheet
As of Dec 2025, total debt of $1.16B exceeded cash and equivalents by $928.21M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.46B | $3.42B | $3.22B | $3.11B | $2.79B | $2.65B | $2.59B | $1.43B | $603.09M | $604.99M |
| Current assets | $1.26B | $1.32B | $1.09B | $994.34M | $710.26M | $657.01M | $558.65M | $467.43M | $186.59M | $173.33M |
| Cash and equivalents | $232.62M | $412.56M | $343.85M | $294.19M | $119.42M | $99.27M | $67.06M | $36.39M | $39.46M | $9.57M |
| Total liabilities | $2.13B | $2.02B | $1.80B | $1.73B | $1.62B | $1.63B | $1.68B | $825.39M | $605.76M | $566.60M |
| Short-term debt | $6.78M | $6.51M | $6.00M | $6.00M | $6.00M | $9.25M | $9.25M | $4.15M | $1.72M | $18.52M |
| Long-term debt | $1.15B | $1.10B | $1.06B | $1.06B | $1.06B | $1.12B | $1.28B | $535.23M | $478.87M | $433.41M |
| Shareholder equity | $1.33B | $1.40B | $1.42B | $1.39B | $1.18B | $1.02B | $906.83M | $602.83M | -$84.75M | -$33.62M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.48B | $3.38B | $3.38B | $3.46B | $3.48B | $3.38B | $3.31B | $3.42B | $3.43B | $3.35B | $3.25B | $3.33B |
| Total liabilities | $2.15B | $2.12B | $2.03B | $2.13B | $2.12B | $2.02B | $1.96B | $2.02B | $2.00B | $1.94B | $1.82B | $1.91B |
| Cash and equivalents | $299.09M | $193.77M | $177.32M | $232.62M | $309.82M | $198.82M | $171.37M | $412.56M | $483.03M | $376.87M | $219.51M | $343.85M |
| Shareholder equity | $1.32B | $1.26B | $1.35B | $1.33B | $1.36B | $1.36B | $1.35B | $1.40B | $1.43B | $1.41B | $1.43B | $1.42B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 84.0% of operating cash flow. Share repurchases came to 142.7% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $258.45M | $323.39M | $371.30M | $267.55M | $208.57M | $127.39M | $39.47M | $24.43M | $37.87M | -$42.54M |
| Capital expenditures | $41.31M | $35.61M | $41.87M | $35.36M | $25.63M | $26.88M | $28.29M | $26.28M | $24.96M | $9.87M |
| Free cash flow | $217.14M | $287.79M | $329.43M | $232.19M | $182.94M | $100.52M | $11.18M | -$1.85M | $12.91M | -$52.41M |
| Dividends paid | N/A | N/A | N/A | N/A | N/A | $904.00K | $2.00M | N/A | N/A | N/A |
| Share repurchases | $309.95M | $252.73M | $250.26M | $0 | $0 | N/A | N/A | N/A | N/A | N/A |
| Investing cash flow | -$161.08M | -$36.47M | -$56.51M | -$108.05M | -$111.54M | -$26.33M | -$727.83M | -$37.00M | -$24.47M | -$73.21M |
| Financing cash flow | -$277.31M | -$218.21M | -$265.13M | $15.27M | -$76.87M | -$68.85M | $719.02M | -$4.15M | -$5.15M | $109.74M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $114.73M | $183.59M | -$12.11M | $35.89M | $139.44M | $90.33M | -$7.21M | $36.12M | $160.40M | $195.66M | -$68.78M | $50.97M |
| Capital expenditures | $6.68M | $11.08M | $9.05M | $13.65M | $9.20M | $9.10M | $9.37M | $10.34M | $9.67M | $9.78M | $5.82M | $19.89M |
| Free cash flow | $108.05M | $172.52M | -$21.16M | $22.25M | $130.24M | $81.24M | -$16.59M | $25.78M | $150.73M | $185.88M | -$74.60M | $31.08M |
Frequently Asked Questions About OPCH
What is Option Care Health's annual revenue?
Option Care Health reported revenue of $5.65B for the fiscal year ended Dec 31, 2025.
How fast is Option Care Health's revenue growing?
Revenue was up 13.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 12.7%.
Is Option Care Health profitable?
Yes. Option Care Health reported net income of $207.59M for the fiscal year ended Dec 31, 2025, with a net margin of 3.7%.
How much free cash flow does OPCH generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $258.45M minus capital expenditures of $41.31M produced free cash flow of $217.14M.
How much debt does Option Care Health have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $1.15B, short-term debt of $6.78M and cash and equivalents of $232.62M.
OPCH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts